DHA sbir PHI topic DHA242-003 proposal H2420030053 title innovative adaptive drug delivery system enhanced neuroprotection repair traumatic brain injuries from penetrating trauma open skull…
Ended Purchase Order Awarded Last action
- Contract number
- HT942525P0002
- Awardee
-
Altrazeal Life Sciences Inc. UEI N24WUMUHT5V9
- Awarding agency
-
Defense Health Agency
Department of Defense
- Obligated
- $250,000
Award facts
- Opportunity
-
- HQ003420RBDST Solicitation number
- Contract value 100% obligated
- $249,999.96 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 541715 Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology)
- Set-aside
- Total Small Business
- Competition
- Full and Open Competition after exclusion of sources · 22 offers Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Addison, TX 75001, USA
- Legislative mandates
-
- Employment Eligibility Verification (E-Verify) FAR subpart 22.18
Award details come from SAM.gov/FPDS.
About this award
The Defense Health Agency awarded a purchase order to Altrazeal Life Sciences Inc. for $249,999.96 on October 7, 2024, under the total small business set-aside category. The order, issued under SBIR Topic DHA242-003 Proposal H2420030053, funds Phase I research into an innovative adaptive drug delivery system for enhanced neuroprotection and repair of traumatic brain injuries resulting from penetrating trauma and open skull fractures in low-resource environments. Work is performed at the contractor's facility in Addison, Texas. The order carries an ultimate completion date of May 6, 2025.
Description
DHA sbir PHI topic DHA242-003 proposal H2420030053 title innovative adaptive drug delivery system enhanced neuroprotection repair traumatic brain injuries from penetrating trauma open skull fractures in low resource envir MED randd EGS24000648
Quick answers
Who was awarded contract HT942525P0002?
HT942525P0002 was awarded to Altrazeal Life Sciences Inc. by Defense Health Agency (Department of Defense) on October 7, 2024.
How much is contract HT942525P0002 worth?
The government has obligated $250,000 on HT942525P0002.
Was contract HT942525P0002 competed?
The extent of competition for HT942525P0002 was full and open competition after exclusion of sources. The government received 22 offers. It was set aside: Total Small Business.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award